Industry: Pharmaceuticals, Biotechnology
ImmPORT’s revolutionary technology enables fast, comprehensive and high-throughput analysis of immune responses to infectious disease antigens. It is ideal for vaccine and diagnostics development or clinical analysis. A pre-printed array for simultaneous serological detection of multiple infectious agents is available in early 2007 (learn more about “PathogenChip”). The technology is also available as a custom whole proteome synthesis, micro-array fabrication and analysis service . The primary competitive benefits are: Much faster results: starting from gene sequences and genomic DNA, we express, array and screen all antigens in the proteome within weeks. ( www.immport-inc.com )
ImmPORT Therapeutics Inc.
Suite E309
Irvine, California 92618
USA
Tel: (949) 679-4068
Fax: (949) 679-4069